Linked Life Data

15583115

Source:http://linkedlifedata.com/resource/pubmed/id/15583115

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2004-12-7
pubmed:abstractText
Inhibitors of steroid synthesis have been reported to exert antidepressive effects, according to preliminary findings.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0003-990X
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1235-44
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15583115-Adrenocorticotropic Hormone, pubmed-meshheading:15583115-Adult, pubmed-meshheading:15583115-Antidepressive Agents, pubmed-meshheading:15583115-Cortodoxone, pubmed-meshheading:15583115-Dehydroepiandrosterone, pubmed-meshheading:15583115-Depressive Disorder, Major, pubmed-meshheading:15583115-Double-Blind Method, pubmed-meshheading:15583115-Drug Synergism, pubmed-meshheading:15583115-Drug Therapy, Combination, pubmed-meshheading:15583115-Enzyme Inhibitors, pubmed-meshheading:15583115-Female, pubmed-meshheading:15583115-Fluvoxamine, pubmed-meshheading:15583115-Humans, pubmed-meshheading:15583115-Male, pubmed-meshheading:15583115-Metyrapone, pubmed-meshheading:15583115-Middle Aged, pubmed-meshheading:15583115-Placebos, pubmed-meshheading:15583115-Psychiatric Status Rating Scales, pubmed-meshheading:15583115-Treatment Outcome, pubmed-meshheading:15583115-Triazoles
pubmed:year
2004
pubmed:articleTitle
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
pubmed:affiliation
Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany. jahn@uke.uni-hamburg.de
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't